Hepcidin Expression in the Anemia of Chronic Disease

铁调素在慢性病贫血中的表达

基本信息

  • 批准号:
    7122012
  • 负责人:
  • 金额:
    $ 12.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-08-01 至 2008-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The pathogenesis of the anemia of chronic disease is not understood. A recently identified peptide, hepcidin, has been found to be aberrantly expressed in hepatic adenomas in GSD (GSD), resulting in an iron-resistant iron-deficiency anemia similar to that seen in the anemia of chronic disease. Hepcidin is postulated to be involved in the pathogenesis of the anemia of chronic disease, and these investigations are aimed at characterizing the role of hepcidin in both normal iron homeostasis and in subjects with the anemia of chronic disease. The specific aims are the following: 1) To evaluate the relationship between adenoma tumor burden and anemia; 2) To characterize iron absorption and distribution in normal controls, anemic patients, and patients with GSD Type 1 at (GSD1a; 3) To compare hepcidin expression in normal individuals and patients with GSD1a, and 4) To determine the role of hepcidin as a mediator of the anemia of chronic disease in patients with other inflammatory conditions. Methodology: The relationship between iron homeostasis and hepcidin expression will be studied in normal and pathologic states including GSD1a, juvenile rheumatoid arthritis, and inflammatory bowel disease. As inappropriate hepcidin expression has been demonstrated in hepatic adenomas in patients with GSD, direct observational studies in this population will be performed to allow further clinical correlation between these lesions and indices of erythropoiesis and iron status. Oral absorption of iron will be investigated in all subjects to define the relationship between hepcidin and iron absorption. For the inflammatory disorders, the oral iron challenge tests and direct measurement of hepcidin will be performed during periods of disease remission and exacerbation. The relationship between hepcidin and inflammatory markers will also be investigated. Through these studies, the role of hepcidin as a mediator of anemia of chronic disease will be elucidated. Improved understanding of the pathophysiology of the anemia of chronic disease will lay the foundation for new treatments for anemia and disorders of iron homeostasis.
描述(由申请人提供): 慢性病贫血的发病机制尚不清楚。最近发现的一种多肽,海普西丁,在GSD(GSD)的肝腺瘤中异常表达,导致一种类似于慢性病贫血的铁抵抗缺铁性贫血。海普西丁被认为与慢性病贫血的发病机制有关,这些研究旨在确定海普西丁在正常铁稳态和慢性病贫血患者中的作用。 其具体目的如下:1)评价腺瘤肿瘤负荷与贫血的关系;2)研究正常对照组、贫血患者和GSD1a 1型GSD患者中铁的吸收和分布特征;3)比较正常人和GSD1a患者中Hepsidin的表达;4)确定在有其他炎症性疾病的患者中,Hepsidin在慢性病贫血中的中介作用。 方法:在正常和病理状态下,包括GSD1a、幼年类风湿性关节炎和炎症性肠病,研究铁稳态和海普西丁表达之间的关系。由于在GSD患者的肝腺瘤中显示出不适当的海普西丁表达,将在这一人群中进行直接的观察性研究,以允许这些病变与红细胞生成和铁状态的指标之间进一步的临床相关性。将对所有受试者的口服铁吸收进行调查,以确定海普西丁和铁吸收之间的关系。对于炎症性疾病,在疾病缓解和恶化期间,将进行口服铁激发试验和直接测定海普西丁。此外,还将研究海普西丁与炎症标志物的关系。通过这些研究,将阐明海普西丁作为慢性病贫血的介体的作用。提高对慢性病贫血的病理生理学的认识,将为治疗贫血和铁稳态紊乱的新疗法奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID A WEINSTEIN其他文献

DAVID A WEINSTEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID A WEINSTEIN', 18)}}的其他基金

AN OPEN-LABEL, CROSSOVER STUDY OF ALTERNATIVE DIETARY THERAPIES FOR GLYCOGEN STO
糖原 STO 替代饮食疗法的开放标签、交叉研究
  • 批准号:
    7380765
  • 财政年份:
    2006
  • 资助金额:
    $ 12.58万
  • 项目类别:
CLINICAL EVALUATION OF PORTABLE LACTATE METER IN TYPE GLYCOGEN STORAGE DISEASE
便携式乳酸计在糖原贮积症中的临床评价
  • 批准号:
    7380733
  • 财政年份:
    2006
  • 资助金额:
    $ 12.58万
  • 项目类别:
CHARACTERIZATION OF THE ROLE OF HEPCIDIN IN THE ANEMIA OF CHRONIC DISEASE
铁皮素在慢性病贫血中的作用特征
  • 批准号:
    7380722
  • 财政年份:
    2006
  • 资助金额:
    $ 12.58万
  • 项目类别:
CLINICAL EVALUATION OF PORTABLE LACTATE METER IN TYPE GLYCOGEN STORAGE DISEASE
便携式乳酸计在糖原贮积症中的临床评价
  • 批准号:
    7204712
  • 财政年份:
    2005
  • 资助金额:
    $ 12.58万
  • 项目类别:
ASSESSMENT OF ABNORMAL GLYCOGEN SYNTHESIS AS A CAUSE OF KETOTIC HYPOGLYCEMIA
评估糖原合成异常作为酮症低血糖的原因
  • 批准号:
    7204665
  • 财政年份:
    2005
  • 资助金额:
    $ 12.58万
  • 项目类别:
CHARACTERIZATION OF AMEMIA OF CHRONIC DISEASE IN TYPE I GLYCOGEN STORAGE DISE
I 型糖原储存病中慢性疾病阿米亚的特征
  • 批准号:
    7204693
  • 财政年份:
    2005
  • 资助金额:
    $ 12.58万
  • 项目类别:
Hepcidin Expression in the Anemia of Chronic Disease
铁调素在慢性病贫血中的表达
  • 批准号:
    6686261
  • 财政年份:
    2003
  • 资助金额:
    $ 12.58万
  • 项目类别:
Hepcidin Expression in the Anemia of Chronic Disease
铁调素在慢性病贫血中的表达
  • 批准号:
    7272051
  • 财政年份:
    2003
  • 资助金额:
    $ 12.58万
  • 项目类别:
Hepcidin Expression in the Anemia of Chronic Disease
铁调素在慢性病贫血中的表达
  • 批准号:
    7173212
  • 财政年份:
    2003
  • 资助金额:
    $ 12.58万
  • 项目类别:
Hepcidin Expression in the Anemia of Chronic Disease
铁调素在慢性病贫血中的表达
  • 批准号:
    6779956
  • 财政年份:
    2003
  • 资助金额:
    $ 12.58万
  • 项目类别:

相似国自然基金

基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
  • 批准号:
    82302715
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
  • 批准号:
    31200592
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
FA/BRCA途径中siRNA干扰和PARP-1抑制剂对多药耐药骨髓瘤细胞株的影响
  • 批准号:
    81001053
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
  • 批准号:
    24K10442
  • 财政年份:
    2024
  • 资助金额:
    $ 12.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
  • 批准号:
    10748859
  • 财政年份:
    2024
  • 资助金额:
    $ 12.58万
  • 项目类别:
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 12.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
  • 批准号:
    23K14452
  • 财政年份:
    2023
  • 资助金额:
    $ 12.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
  • 批准号:
    23KJ0074
  • 财政年份:
    2023
  • 资助金额:
    $ 12.58万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Iron deficits and their relationship with symptoms and cognition in Psychotic Spectrum Disorders
铁缺乏及其与精神病谱系障碍症状和认知的关系
  • 批准号:
    10595270
  • 财政年份:
    2023
  • 资助金额:
    $ 12.58万
  • 项目类别:
A novel peptide assay for hepcidin clinical monitoring
一种用于铁调素临床监测的新型肽测定方法
  • 批准号:
    10698746
  • 财政年份:
    2023
  • 资助金额:
    $ 12.58万
  • 项目类别:
Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates
用于骨髓抽吸物实时充分性分析的深紫外显微镜
  • 批准号:
    10761397
  • 财政年份:
    2023
  • 资助金额:
    $ 12.58万
  • 项目类别:
Deciphering the molecular mechanism of ineffective erythropoiesis in MDS-5q
破译MDS-5q无效红细胞生成的分子机制
  • 批准号:
    10773217
  • 财政年份:
    2023
  • 资助金额:
    $ 12.58万
  • 项目类别:
Regulation of erythroid iron metabolism by the CLPX unfoldase
CLPX 解折叠酶对红细胞铁代谢的调节
  • 批准号:
    10716494
  • 财政年份:
    2023
  • 资助金额:
    $ 12.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了